In Angola, all trademark applications are subject to examination
by the Angolan Institute of Industrial Property
(IAPI). During this process, if the institute concludes
that there are grounds for refusal as specified under Articles
31(1) and 35 of the Angolan Industrial Property Law, it will
publish the refusal in the Industrial Property
Bulletin.
In 2018, several publications in the Industrial
Property Bulletin stated that applications had not been
regulated as per the Industrial Property Law – namely, they
violated the World Health Organisation's (WHO's)
international non-proprietary name (INN) rules. An
'INN' is an official generic and non-proprietary
name given to a pharmaceutical drug or an active
ingredient, which provides a unique standard name for each active
ingredient.
